您要查找的是不是：
- MIXED过程Mixed procedure
- MIXED-CONTROLMIXED-CONTROL
- mixed congruence method (计算数学)混合同余法
- mixed hyperlipoproteinemia type Ⅰ and Ⅳ高乳糜微粒血症及前β脂蛋白增高(Ⅰ型和Ⅳ型混合型高脂蛋白血症, 即Ⅴ型高脂蛋白血症)
- mixed capillarycavernous hemangioma混合性毛细血管-海绵状血管瘤
- mixed cellularity type of Hodgkins disease混合型何杰金氏病
- Mixed-HSCT后应用DLI+IL-2,可能是有效提高长期生存率的免疫生物治疗措施之一。Immuno-biotherapy with DLI +IL-2 after Mixed-HSCT in patients of acute myelogenous leukemia may be a method to increase DFS efficiently.
- 在理解切换到SQL Server Mixed Mode安全性的安全意义之前,最好保留为默认模式。It's a good idea to leave the default until you understand the security implications of switching to SQL Server Mixed Mode security.
- 经过1~5年观察,8例患者Mixed-HSCT后应用DLI+IL-2治疗的患者长期生存率为62.5%。Result DFS in 8 cases of patients with acute myelogenous leukemia received Mixed-HSCT and treated with DLI +IL-2 for 2-7 times were 62.5%25. There were no GVHD.
- mixed -HSCT :19/ 3 3例 (2 4.2% )复发死亡 ; 6/ 3 3例 (18.2% )移植相关死亡 ;mixed-HSCT:8/33(24.2%25) patients died from TRM and 6/33(18.2%25)from relapse;
- 如果您想用另一个用户名密码对进行SQL Server认证,请选择Mixed Mode并输入适当的信息。If you want to have a different username password pair for SQL Server Authentication, select Mixed Mode and enter the appropriate information.
- 方法8例急性髓性白血病患者在完全缓解期实施了Mixed-HSCT,于造血恢复后,给予DLI+IL-2治疗2~7次,并随访观察临床疗效。MethodAfter times of chemotherapy,8 cases of patients with acute myelogenous leukemia received Mixed-HSCT,then were treated with DLI +IL-2 for 2-7 times.
- Mixed过程提供了丰富的协方差结构，可以充分利用重复测量资料的信息，又能处理缺失值，是重复测量资料最优的统计分析方法。And the MIXED procedure of the SAS System provides a rich selection of covariance structures through the RANDOM and REPEATED statements.
- 本文提出了一种简单的可扩展性QoS路由算法Single Mixed Metric based on Link-States,简称SMM_LS算法,是改进的Dijk-stra算法。This paper proposes a simple scalable QoS routing algorithm-single mixed metric based on link_states, SMM_LS for short, which is a modified Dijkstra algorithm.
- 目的探讨急性髓性白血病在经过混合造血干细胞移植(mixed-HSCT)后,应用供体淋巴细胞输注(DLI)+白介素-2(IL-2)作为后续免疫生物治疗措施的意义。Objective To approach curative effect of using DLI +IL-2 as immunobiotherapy after Mixed-HSCT in acute myelogenous leukemia.
